• 1
    Larsson LI, Alm A, Lithner F, Dahlén G, Bergström R. The association of hyperlipidemia with retinopathy in diabetic patients aged 15–50 years in the county of Umeå. Acta Ophthalmol Scand 1999; 77: 58591.
  • 2
    Guyton JR, Dahlén GH, Patch W, Kautz JA, Gotto AM Jr. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis 1985; 5: 26572.
  • 3
    Dahlén GH. Incidence of Lp(a) among populations. In: Scanu AM, ed. Lipoprotein(a). San Diego, CA, USA: Academic Press. 1990; 151–73.
  • 4
    Thorsen K, Nordström P, Lorentzon R, Dahlén GH. The relation between bone mineral density, insulin-like growth factor I, lipoprotein (a), body composition, and muscle strength in adolescent males. J Clin Endocrinol Metab 1999; 84: 30259.
  • 5
    Brown MS & Goldstein JL. Teaching old dogmas new tricks. Nature 1987; 330: 1134.
  • 6
    Dahlén GH. Lipoprotein(a) as a risk factor for atherosclerotic diseases. Arctic Med Res 1988; 47 (Suppl. 1): 45861.
  • 7
    Dahlén GH, Weinehall L, Stenlund H, Jansson J-H, Hallmans G. Lipoprotein (a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case–control study from Sweden. J Intern Med 1998; 244: 42530.